Physician
Cherubini, Blanki
Cherubini, Blanki was paid $57K by Medicaid between Jan 2018 and Aug 2022, across 8 billing codes. Its largest line is 99204, doctor's office visit, new patient (more involved) — 40% of everything it billed.
33Billing provider infoCHERUBINI, BLANKI
CRANSTON, RI 02920
CRANSTON, RI 02920
33aNPI1902232358assigned 09/17/2013
33bProvider typePhysical Medicine & Rehabilitation Physician
28Total paid$57K
24GClaims1,101
24DCodes billed8
24AFirst – last monthJan 2018 – Aug 2022
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 50 | $3K | |
| 2019 | 110 | $3K | |
| 2020 | 268 | $11K | |
| 2021 | 481 | $28K | |
| 2022 | 192 | $12K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 40% | 246 | 228 | $23K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 25% | 280 | 261 | $14K |
| 95886 | 22% | 202 | 181 | $12K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 4.4% | 198 | 139 | $3K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.1% | 37 | 36 | $2K |
| 95909 | 3.1% | 26 | 24 | $2K | |
| 76942 | 2.8% | 26 | 25 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 86 | 50 | $108.19 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.